Neural Systems Underlying Opiate Addiction

Journal of Neuroscience

Volumn 22, Issue 9, 2002, Pages 3321-3325

  De Vries, Taco J ^a   Shippenberg, Toni S ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NARCOTIC AGENT; NEUROPEPTIDE;

AMYGDALOID NUCLEUS; DOPAMINE RELEASE; DRUG DEPENDENCE; HUMAN; NERVOUS SYSTEM; NEUROLOGIC EXAMINATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SHORT SURVEY; VENTRAL TEGMENTUM; ADAPTATION; ANIMAL; DRUG EFFECT; MOTIVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RECURRENT DISEASE; REVIEW; STRESS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; HUMANS; MOTIVATION; NARCOTICS; NERVOUS SYSTEM; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; OPIOID-RELATED DISORDERS; RECURRENCE; STRESS;

EID: 0036581179     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-09-03321.2002     Document Type: Short Survey

References (68)

1. Ahmed SH, Walker JR, Koob GF (2000) Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22:413-421.
2. Alderson HL, Robbins TW, Everitt BJ (2000) Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats. Psychopharmacology 153:120-133.
3. Bechara A, K Nader K, Van der Kooy D (1998) A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol Biochem Behav 59:1-17.
4. Bronstein D, Trujillio K, Akil H, (1988) Effects of morphine treatment on endogenous opioid biosynthesis. NIDA Res Monogr 90:256-265.
5. Cahill CM, Morinville A, Lee M-C, Vincent J-P, Collier B, Beaudet A (2001) Prolonged morphine treatment targets δ opioid receptors to neuronal plasma membranes and enhances δ-mediated antinociception. J Neurosci 21:7598-7607.
6. Chang JY, Janak PH, Woodward DH (1998) Comparison of mesocorticolimbic neuronal responses during cocaine and heroin self-administration in freely moving rats. J Neurosci 18:3098-3115.
7. Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20:11-15.
8. Davis WM, Smith SG (1976) Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pavlovian J Biol Sci 11:222-236.
9. De Vries TJ, Schoffelmeer ANM, Binnekade R, Mulder AH, Vanderschuren LJMJ (1998) Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 10:3565-3571.
10. De Vries TJ, Schoffelmeer ANM, Binnekade R, Vanderschuren LJMJ (1999) Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology 143:254-260.
11. De Vries TJ, Schoffelmeer ANM, Binnekade R, Raasø H, Vanderschuren LJMJ (2002) Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26:18-26.
12. Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL (1993) Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci USA 90:7966-7969.
13. DiChiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
14. Dockstader CL, Rubinstein M, Grandy DK, Low MJ, van der Kooy D (2001) The D-2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice. Eur J Neurosci 13:995-1001.
15. Druhan JP, Walters CL, Aston-Jones G (2000) Behavioral activation induced by D-2-like receptor stimulation during opiate withdrawal. J Pharmacol Exp Ther 294:531-538.
16. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204-209.
17. Ettenberg A, MacConell LA, Geist TD (1996) Effects of haloperidol in a response-reinstatement model of heroin relapse. Psychopharmacology 124:205-210.
18. Everitt BJ, Robbins TW (2000) Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology 153:17-30.
19. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25:195-200.
20. Funada M, Shippenberg TS (1996) Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behav Pharmacol 7:448-453.
21. Funada M, Schutz CG, Shippenberg TS (1996) Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. Eur J Pharmacol 300:17-24.
22. Grimm JW, Hope BT, Wise RA, Shaham Y (2001) Neuroadaptation: incubation of cocaine craving after withdrawal. Nature 412:141-142.
23. Groenewegen HJ, Wright CI, Beijer VJ (1996) The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog Brain Res 107:485-551.
24. Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371:155-157.
25. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A (2001) The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 4:943-947.
26. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488.
27. Kiyatkin EA, Wise RA, Gratton A (1993) Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats. Synapse 14:60-72.
28. Koob GF, Stinus L, Le Moal M, Bloom FE (1989) Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13:135-140.
29. Koob GF, Sanna PP, Bollm FE (1998) Neuroscience of addiction. Neuron 21:467-476.
30. Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51:23-47.
31. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401-404.
32. Maldonado R, Blendy J, Tzavara E, Gass P, Roques BP, Hanoune J, Schutz G (1996) Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273:657-659.
33. Mansour M, Fox CA Burke S, Akil H, Watson SJ (1995) Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8:283-305.
34. Manzanares A, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287-294.
35. Mas-Nieto M, Pommier B, Tzavara ET, Caneparo A, Da Nascimento S, Le Fur G, Rogues BP, Noble F (2001) Reduction of opioid dependence by the CB1 antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. Br J Pharmacol 132:1809-1816.
36. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383:819-823.
37. McFarland K, Ettenberg A (1997) Reinstatement of drug-seeking behavior produced by heroin-predictive environmental stimuli. Psychopharmacology 131:86-92.
38. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
39. Mogenson GJ, Jones DL, Yin CY (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14:69-97.
40. Negus SS, Burke TF, Medzihradsky F, Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267:896-903.
41. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
42. Olive MF, Maidment NT (1998) Repeated heroin administration increases extracellular opioid peptide-like immunoreactivity in the globus pallidus/ventral pallidum of freely moving rats. Psychopharmacology 139:251-254.
43. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776.
44. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
45. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
46. Sarnyai Z, Shaham Y, Heinrichs SC (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53:209-243.
47. Schultz W, Tremblay L, Hollerman J (1998) Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37:421-429.
48. Self DW, Nestler EJ (1998) Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend 51:49-60.
49. Shaham Y, Stewart J (1995) Stress reinstates heroin-seeking in drug free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119:334-341.
50. Shaham Y, Stewart J (1996) Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology 125:385-391.
51. Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 16:1957-1963.
52. Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33:13-33.
53. Shalev U, Morales M, Hope B, Yap J, Shaham Y (2000) Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology 156:98-107.
54. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1-42.
55. Shippenberg TS, Elmer G (1998) The neurobiology of opiate reinforcement. Crit Rev Neurobiol 14:267-303.
56. Shippenberg TS, Heidbreder C, LeFevour A (1996) Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 299:33-39.
57. Shippenberg TS, Chefer VI, Zapata A, Heidbreder C (2001) Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Ann NY Acad Sci 937:50-73.
58. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, Kieffer BL (1998) Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. EMBO J 17:886-897.
59. Spanagel R, Sillaber I, Zieglgansberger W, Corrigall WA, Stewart J, Shaham Y (1998) Acamprosate suppresses the expression of morphine induced sensitization in rats but does not affect heroin self administration or relapse induced by heroin or stress. Psychopharmacology 139:391-401.
60. Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25:125-136.
61. Stinus L, Le Moal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773.
62. Trujillo KA (2000) Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology 151:121-141.
63. Vanderschuren LJMJ, Schoffelmeer ANM, Mulder AH, De Vries TJ (1999) Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology 143:244-253.
64. Vanderschuren LJMJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99-120.
65. Wikler A (1948) Recent progress in research on the neurophysiological basis of morphine addiction. Am J Psychiatry 105:329-338.
66. Wise RA, Murray A, Bozarth MA (1990) Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology 100:355-360.
67. Xi ZX, Stein EA (1999) Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther 290:1369-1374.
68. Zito KA, Vickers G, Roberts DC (1985) Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol Biochem Behav 23:1029-1036.